Colistin Resistance among Enterobacteriaceae Isolated from Clinical Samples in Gaza Strip
Publication Type
Original research
Authors

Bacterial infections, especially drug-resistant infections, are a major global health issue. (e emergence of multidrug-resistant (MDR) strains of Enterobacteriaceae and the lack of new antibiotics have worrisome prospects for all of humanity. Colistin is considered the last-line drug for MDR Gram-negative bacteria (GNB), and it is often used for treatment of respiratory infections caused by MDR-GNB. In recent years, there has been a marked increase in the incidence of colistin-resistant infections. (e main objective of this study was to investigate the presence of colistin resistance among clinical GNB isolated from Gaza Strip hospitals. Clinical Enterobacteriaceae isolates (100) were obtained from microbiology laboratories of the hospitals of different geographical locations in Gaza Strip Governorate over a period of six months. Samples were cultured, and bacterial identification was performed by standard microbiological procedures. Enterobacteriaceae isolates were tested for their antimicrobial susceptibility by the disk diffusion method and the MIC method for colistin. Varying degrees of susceptibility were observed for the isolates against the tested antimicrobials even within members of the same antimicrobial class. Amikacin was the most effective drug (74%), followed by chloramphenicol (48%), fosfomycin, and gentamicin (45%). High resistance was recorded against trimethoprim (85%) and tetracycline (83%). Only 59% of the tested isolates were interpreted as susceptible, while 41% was classified as resistant. (e highest resistance to colistin was found to be among the Proteus spp. (63.2%), followed by Serratia spp. (57.1%). (e lowest resistance was observed among Klebsiella isolates (31.6%). Only 39.0% of meropenem-resistant Enterobacteriaceae was susceptible to colistin, while 45.8% of imipenem-resistant Enterobacteriaceae was susceptible to colistin. (e overall resistance to colistin was high (41%) among tested clinical isolates. Furthermore, 89% was MDR. (ese limit and complicate treatment options for the infections caused by Enterobacteriaceae in Gaza Strip. (is calls for immediate actions to control and monitor the use of antimicrobials in general and colistin in particular.

Journal
Title
Canadian Journal of Infectious Diseases and Medical Microbiology
Publisher
Hindawi
Publisher Country
Egypt
Indexing
Scopus
Impact Factor
2.471
Publication Type
Both (Printed and Online)
Volume
2021
Year
2021
Pages
--